Sponsor Deadline:
May 21, 2020
Sponsor:
Medical Technology Enterprise Consortium MTEC
UI Contact:
Updated Date:
Apr 24, 2020
MTEC Post-traumatic Stress Disorder-Drug Treatment (PTSD-DT) Adaptive Platform Trial (APT)
Solicitation Number: MTEC 20-11-PTSD-DT
https://www.mtec-sc.org/wp-content/uploads/2020/04/20-11-PTSD-DT-RPP.pdf
Proposals are due May 21, 2020.
The University of Iowa is a member of MTEC.
- Focus Area #1 (Statistical Modeling): Trial design, simulation, initiation, and execution, including drafting of key documents (e.g., statistical sections of Master Protocol, Statistical Analysis Plan, Operational Plan).
- Focus Area #2 (Drug Selection): Operationalization and execution of a drug selection process for initial and continual selection of interventions to be tested in the APT.
- Focus Area #3 (Clinical and Clinical Operations): Completion of the APT design, development of clinical trial infrastructure, and execution of the APT.